269 related articles for article (PubMed ID: 33123800)
1. Scutellarin is Highly Likely to be Responsible for Drug-Drug Interactions Mediated by Hepatic Organic Anion-Transporting Polypeptide1B3.
Liu J; Guo Y; Xu Y; Yuan L; Zhu H
Pharm Res; 2020 Oct; 37(12):232. PubMed ID: 33123800
[TBL] [Abstract][Full Text] [Related]
2. Scutellarin inhibition of the rosuvastatin uptake in rat hepatocytes and the competition for organic anion transporting polypeptide 1B1 in HEK293T cells.
Liu J; Guo Y; Liu K; Ye X; Wang F; Xu Y; Xia C
Sci Rep; 2020 Jan; 10(1):1308. PubMed ID: 31992796
[TBL] [Abstract][Full Text] [Related]
3. Physiologically Based Pharmacokinetic Modeling of Rosuvastatin to Predict Transporter-Mediated Drug-Drug Interactions.
Hanke N; Gómez-Mantilla JD; Ishiguro N; Stopfer P; Nock V
Pharm Res; 2021 Oct; 38(10):1645-1661. PubMed ID: 34664206
[TBL] [Abstract][Full Text] [Related]
4. Calibrating the In Vitro-In Vivo Correlation for OATP-Mediated Drug-Drug Interactions with Rosuvastatin Using Static and PBPK Models.
Sane R; Cheung KWK; Kovács P; Farasyn T; Li R; Bui A; Musib L; Kis E; Plise E; Gáborik Z
Drug Metab Dispos; 2020 Dec; 48(12):1264-1270. PubMed ID: 33037044
[TBL] [Abstract][Full Text] [Related]
5. Effect of scutellarin on the metabolism and pharmacokinetics of clopidogrel in rats.
Chen X; Jin J; Chen Y; Peng L; Zhong G; Li J; Bi H; Cai Y; Huang M
Biopharm Drug Dispos; 2015 Jan; 36(1):64-8. PubMed ID: 25256597
[TBL] [Abstract][Full Text] [Related]
6. Interaction of Sulfonylureas with Liver Uptake Transporters OATP1B1 and OATP1B3.
Chen Y; Chen L; Zhang H; Huang S; Xiong Y; Xia C
Basic Clin Pharmacol Toxicol; 2018 Aug; 123(2):147-154. PubMed ID: 29498478
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a potential transporter-mediated drug interaction between rosuvastatin and pradigastat, a novel DGAT-1 inhibitor.
Kulmatycki K; Hanna I; Meyers D; Salunke A; Movva A; Majumdar T; Natrillo A; Vapurcuyan A; Rebello S; Sunkara G; Chen J
Int J Clin Pharmacol Ther; 2015 May; 53(5):345-55. PubMed ID: 25740267
[TBL] [Abstract][Full Text] [Related]
8. Hepatic Uptake Mechanism of Ophiopogonin D Mediated by Organic Anion Transporting Polypeptides.
Zhang W; Xiong X; Chen L; Liu M; Xiong Y; Zhang H; Huang S; Xia C
Eur J Drug Metab Pharmacokinet; 2017 Aug; 42(4):669-676. PubMed ID: 27815731
[TBL] [Abstract][Full Text] [Related]
9. Investigating Transporter-Mediated Drug-Drug Interactions Using a Physiologically Based Pharmacokinetic Model of Rosuvastatin.
Wang Q; Zheng M; Leil T
CPT Pharmacometrics Syst Pharmacol; 2017 Apr; 6(4):228-238. PubMed ID: 28296193
[TBL] [Abstract][Full Text] [Related]
10. Black tea extract and theaflavin derivatives affect the pharmacokinetics of rosuvastatin by modulating organic anion transporting polypeptide (OATP) 2B1 activity.
Kondo A; Narumi K; Okuhara K; Takahashi Y; Furugen A; Kobayashi M; Iseki K
Biopharm Drug Dispos; 2019 Sep; 40(8):302-306. PubMed ID: 31400238
[TBL] [Abstract][Full Text] [Related]
11. Functional characterization for polymorphic organic anion transporting polypeptides (OATP/SLCO1B1, 1B3, 2B1) of monkeys recombinantly expressed with various OATP probes.
Takahashi T; Uno Y; Yamazaki H; Kume T
Biopharm Drug Dispos; 2019 Feb; 40(2):62-69. PubMed ID: 30652318
[TBL] [Abstract][Full Text] [Related]
12. Dissecting the Contribution of OATP1B1 to Hepatic Uptake of Statins Using the OATP1B1 Selective Inhibitor Estropipate.
Zhang Y; Panfen E; Fancher M; Sinz M; Marathe P; Shen H
Mol Pharm; 2019 Jun; 16(6):2342-2353. PubMed ID: 31039308
[TBL] [Abstract][Full Text] [Related]
13. Glycyrrhizin has a high likelihood to be a victim of drug-drug interactions mediated by hepatic organic anion-transporting polypeptide 1B1/1B3.
Dong J; Olaleye OE; Jiang R; Li J; Lu C; Du F; Xu F; Yang J; Wang F; Jia W; Li C
Br J Pharmacol; 2018 Sep; 175(17):3486-3503. PubMed ID: 29908072
[TBL] [Abstract][Full Text] [Related]
14. Impact of curcumin on the pharmacokinetics of rosuvastatin in rats and dogs based on the conjugated metabolites.
Zhou X; Zhang F; Chen C; Guo Z; Liu J; Yu J; Xu Y; Zhong D; Jiang H
Xenobiotica; 2017 Mar; 47(3):267-275. PubMed ID: 27174018
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic herb-disease-drug interactions: Effect of ginkgo biloba extract on the pharmacokinetics of pitavastatin, a substrate of Oatp1b2, in rats with non-alcoholic fatty liver disease.
Li Z; Tian S; Wu Z; Xu X; Lei L; Li Y; Wang B; Huang Y
J Ethnopharmacol; 2021 Nov; 280():114469. PubMed ID: 34329714
[TBL] [Abstract][Full Text] [Related]
16. Preincubation With Everolimus and Sirolimus Reduces Organic Anion-Transporting Polypeptide (OATP)1B1- and 1B3-Mediated Transport Independently of mTOR Kinase Inhibition: Implication in Assessing OATP1B1- and OATP1B3-Mediated Drug-Drug Interactions.
Farasyn T; Crowe A; Hatley O; Neuhoff S; Alam K; Kanyo J; Lam TT; Ding K; Yue W
J Pharm Sci; 2019 Oct; 108(10):3443-3456. PubMed ID: 31047942
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Effects of Repeat-Dose Dabrafenib on the Single-Dose Pharmacokinetics of Rosuvastatin (OATP1B1/1B3 Substrate) and Midazolam (CYP3A4 Substrate).
Nebot N; Won CS; Moreno V; Muñoz-Couselo E; Lee DY; Gasal E; Bouillaud E
Clin Pharmacol Drug Dev; 2021 Sep; 10(9):1054-1063. PubMed ID: 33932130
[TBL] [Abstract][Full Text] [Related]
18. Modulation of transporter activity of OATP1B1 and OATP1B3 by the major active components of Radix Ophiopogonis.
Chen L; Liu L; Chen Y; Liu M; Xiong Y; Zhang H; Huang S; Xia C
Xenobiotica; 2019 Oct; 49(10):1221-1228. PubMed ID: 29944058
[No Abstract] [Full Text] [Related]
19. Prediction of drug-drug interaction potential mediated by transporters between dasatinib and metformin, pravastatin, and rosuvastatin using physiologically based pharmacokinetic modeling.
Chang M; Bathena S; Christopher LJ; Shen H; Roy A
Cancer Chemother Pharmacol; 2022 Mar; 89(3):383-392. PubMed ID: 35147740
[TBL] [Abstract][Full Text] [Related]
20. Effect of Rifampin-Mediated OATP1B1 and OATP1B3 Transporter Inhibition on the Pharmacokinetics of the P2Y12 Receptor Antagonist Selatogrel.
Schilling U; Dingemanse J; Voors-Pette C; Romeijn C; Dogterom P; Ufer M
Clin Transl Sci; 2020 Sep; 13(5):886-890. PubMed ID: 32166864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
